News | April 01, 2025
Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
Vision loss due to Glaucoma can be prevented if it is detected and treated early
First of its kind screening for Glaucoma at grass root level over 10k screened already
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
Subscribe To Our Newsletter & Stay Updated
